BlackRock
GRI

BlackRock’s GRI Bio GRI Stock Holding History

BlackRock’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12 Hold
7
– – ﹤0.01% 5669
2026
Q1 		$16 Sell
7
-1
-13% -$4 ﹤0.01% 5654
2025
Q4 		$52 Hold
8
– – ﹤0.01% 5489
2025
Q3 		$435 Hold
8
– – ﹤0.01% 5371
2025
Q2 		$272 Hold
8
– – ﹤0.01% 5391
2025
Q1 		$675 Hold
8
– – ﹤0.01% 5343
2024
Q4 		$2.98K Hold
8
– – ﹤0.01% 5262
2024
Q3 		$1.3K Sell
8
-1
-11% -$402 ﹤0.01% 5128
2024
Q2 		$8.25K Buy
+9
New +$21.4K ﹤0.01% 5087
2021
Q2 		– Hold
0
– -$3K – 5513
2021
Q1 		– Hold
0
– – – 5178

Other funds holding GRI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

BlackRock's GRI Position: Q2 2026 in Review

BlackRock held its GRI Bio (GRI) position steady in Q2 2026 at 7 shares worth $12. The position accounts for ﹤0.01% of the portfolio, ranked #5669.

BlackRock first reported a position in GRI in Q2 2024 and has held it in 9 quarters since. The position peaked at $8.25K in Q2 2024. 8 funds tracked by Wall St. Rank hold GRI as of Q2 2026.

  • BlackRock held 7 shares of GRI Bio worth $12 as of Q2 2026.
  • BlackRock left its GRI Bio share count unchanged in Q2 2026.
  • GRI Bio made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5669 holding.
  • BlackRock first reported a position in GRI Bio in Q2 2024 and has held it in 9 quarters since.
  • BlackRock's GRI Bio position peaked at $8.25K in Q2 2024.
  • 8 funds tracked by Wall St. Rank held GRI Bio as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.